Keywords: horizon, acquires, robinul, forte, wyeth-ayerst, pharmaceutical, corp

Horizon acquires Robinul and Robinul Forte from Wyeth-Ayerst

Article | 04 February 1999

- Horizon Pharmaceutical Corp has acquired Robinul (glycopyrrolate)and Robinul Forte in the USA from Wyeth-Ayerst Laboratories. The drugs are indicated ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Wyeth

Go to company listing

Related Drugs

Glycopyrrolate

Robinul

Go to drug listing